# Hepatitis C Treatment and Atherosclerosis

> **NCT00659256** · — · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 70 (actual)

## Conditions studied

- Chronic Hepatitis C
- Atherosclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00659256
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-08
- **Primary completion:** —
- **Final completion:** 2015-03-24
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659256, "Hepatitis C Treatment and Atherosclerosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00659256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*